Trade LABT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Lakewood-Amedex Biotherapeutics Inc. (LABT) is trading at US$2.41, down 3.05% today as of Aug 28, 09:54 EDT. The company has a market capitalisation of US$5.31M. Over the past 52 weeks, LABT has traded between US$0.58 and US$9.82. On Syfe you can trade LABT with $0 commission and add it to your watchlist.
| Previous close | US$2.49 |
|---|---|
| Market cap | US$5.31M |
| 52-week range | US$0.58 – US$9.82 |
| Volume | 208.89K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics, Inc. engages in the development of novel antimicrobial therapies. Its anti-infective products targeted certain viral diseases like avian influenza, Epstein Barr Virus (EBV), and hepatitis B and C. The company was founded by Roderic Dale on July 11, 2006 and is headquartered in Bradenton, FL.
Year: 2026
Lakewood-Amedex Biotherapeutics Inc. (LABT) stock is trading at US$2.41, -3.05% from the previous close of US$2.49.
The market cap for Lakewood-Amedex Biotherapeutics Inc. (LABT) stock is approximately US$5.31M.
The 52-week high for Lakewood-Amedex Biotherapeutics Inc. (LABT) stock is US$9.82.
The 52-week low for Lakewood-Amedex Biotherapeutics Inc. (LABT) stock is US$0.58.
Lakewood-Amedex Biotherapeutics Inc. (LABT) does not currently pay a dividend.
Stay on top of LABT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
